JP2013503875A5 - - Google Patents

Download PDF

Info

Publication number
JP2013503875A5
JP2013503875A5 JP2012527985A JP2012527985A JP2013503875A5 JP 2013503875 A5 JP2013503875 A5 JP 2013503875A5 JP 2012527985 A JP2012527985 A JP 2012527985A JP 2012527985 A JP2012527985 A JP 2012527985A JP 2013503875 A5 JP2013503875 A5 JP 2013503875A5
Authority
JP
Japan
Prior art keywords
alkyl
heterocyclyl
heteroaryl
conr
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012527985A
Other languages
English (en)
Japanese (ja)
Other versions
JP5643312B2 (ja
JP2013503875A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/047430 external-priority patent/WO2011028741A1/en
Publication of JP2013503875A publication Critical patent/JP2013503875A/ja
Publication of JP2013503875A5 publication Critical patent/JP2013503875A5/ja
Application granted granted Critical
Publication of JP5643312B2 publication Critical patent/JP5643312B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012527985A 2009-09-03 2010-09-01 カリウムイオンチャネルインヒビターとしてのキナゾリン Active JP5643312B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23945209P 2009-09-03 2009-09-03
US61/239,452 2009-09-03
PCT/US2010/047430 WO2011028741A1 (en) 2009-09-03 2010-09-01 Quinazolines as potassium ion channel inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014221908A Division JP5950978B2 (ja) 2009-09-03 2014-10-30 カリウムイオンチャネルインヒビターとしてのキナゾリン

Publications (3)

Publication Number Publication Date
JP2013503875A JP2013503875A (ja) 2013-02-04
JP2013503875A5 true JP2013503875A5 (cg-RX-API-DMAC7.html) 2013-04-25
JP5643312B2 JP5643312B2 (ja) 2014-12-17

Family

ID=42942118

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012527985A Active JP5643312B2 (ja) 2009-09-03 2010-09-01 カリウムイオンチャネルインヒビターとしてのキナゾリン
JP2014221908A Active JP5950978B2 (ja) 2009-09-03 2014-10-30 カリウムイオンチャネルインヒビターとしてのキナゾリン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014221908A Active JP5950978B2 (ja) 2009-09-03 2014-10-30 カリウムイオンチャネルインヒビターとしてのキナゾリン

Country Status (32)

Country Link
US (9) US8575184B2 (cg-RX-API-DMAC7.html)
EP (3) EP2473487B1 (cg-RX-API-DMAC7.html)
JP (2) JP5643312B2 (cg-RX-API-DMAC7.html)
KR (1) KR101698631B1 (cg-RX-API-DMAC7.html)
CN (1) CN102753535B (cg-RX-API-DMAC7.html)
AR (1) AR078326A1 (cg-RX-API-DMAC7.html)
AU (1) AU2010289641B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012008330B1 (cg-RX-API-DMAC7.html)
CA (1) CA2772642C (cg-RX-API-DMAC7.html)
CL (1) CL2012000583A1 (cg-RX-API-DMAC7.html)
CO (1) CO6511220A2 (cg-RX-API-DMAC7.html)
CY (2) CY1118488T1 (cg-RX-API-DMAC7.html)
DK (2) DK3575288T3 (cg-RX-API-DMAC7.html)
EA (1) EA021113B1 (cg-RX-API-DMAC7.html)
ES (3) ES2900504T3 (cg-RX-API-DMAC7.html)
HR (2) HRP20161669T1 (cg-RX-API-DMAC7.html)
HU (2) HUE057433T2 (cg-RX-API-DMAC7.html)
IL (1) IL218169A (cg-RX-API-DMAC7.html)
LT (2) LT3575288T (cg-RX-API-DMAC7.html)
MX (1) MX2012002099A (cg-RX-API-DMAC7.html)
MY (1) MY160243A (cg-RX-API-DMAC7.html)
NZ (1) NZ598516A (cg-RX-API-DMAC7.html)
PE (1) PE20121153A1 (cg-RX-API-DMAC7.html)
PL (2) PL2473487T3 (cg-RX-API-DMAC7.html)
PT (2) PT2473487T (cg-RX-API-DMAC7.html)
SG (1) SG178592A1 (cg-RX-API-DMAC7.html)
SI (2) SI3575288T1 (cg-RX-API-DMAC7.html)
SM (3) SMT202100717T1 (cg-RX-API-DMAC7.html)
TN (1) TN2012000063A1 (cg-RX-API-DMAC7.html)
TW (1) TWI488851B (cg-RX-API-DMAC7.html)
WO (1) WO2011028741A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201202383B (cg-RX-API-DMAC7.html)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH068949B2 (ja) 1985-09-20 1994-02-02 富士写真フイルム株式会社 ハロゲン化銀カラ−写真感光材料
EP2473487B1 (en) 2009-09-03 2016-10-26 Bristol-Myers Squibb Company Quinazolines as potassium ion channel inhibitors
AR079814A1 (es) * 2009-12-31 2012-02-22 Otsuka Pharma Co Ltd Compuestos heterociclicos, composiciones farmaceuticas que los contienen y sus usos
BR112013033417A2 (pt) * 2011-06-29 2016-08-16 Otsuka Pharma Co Ltd compostos terapêuticos e métodos relacionados de uso
JP6121658B2 (ja) * 2011-06-29 2017-04-26 大塚製薬株式会社 治療用化合物、及び関連する使用の方法
WO2013143319A1 (zh) * 2012-03-26 2013-10-03 中国科学院福建物质结构研究所 喹唑啉衍生物及其用途
PT2858987T (pt) * 2012-06-11 2018-07-04 Bristol Myers Squibb Co Profármacos de ácido fosforamídico de 5-[5-fenil-4-(piridin-2-ilmetilamino)quinazolin -2-il]piridina-3-sulfonamida
JP6343600B2 (ja) 2013-02-28 2018-06-13 武田薬品工業株式会社 スルホニルクロライド化合物の製造法
US9403834B2 (en) 2013-03-11 2016-08-02 Bristol-Myers Squibb Company Pyrrolotriazines as potassium ion channel inhibitors
JP2016516691A (ja) * 2013-03-11 2016-06-09 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company カリウムイオンチャネル阻害剤としてのイソキノリン
US9242966B2 (en) * 2013-03-11 2016-01-26 Bristol-Myers Squibb Company Phthalazines as potassium ion channel inhibitors
CN105008366B (zh) 2013-03-11 2017-11-14 百时美施贵宝公司 作为钾离子通道抑制剂的吡咯并哒嗪类化合物
US9050345B2 (en) * 2013-03-11 2015-06-09 Bristol-Myers Squibb Company Pyrrolotriazines as potassium ion channel inhibitors
BR112016008406B1 (pt) * 2013-10-17 2021-02-23 Sumitomo Chemical Company, Limited composto de tetrazolinona e aplicação do mesmo
EP3156395B1 (en) 2014-06-10 2019-01-09 UBE Industries, Ltd. Method for producing heteroaromatic sulfonamide compound
US10774072B2 (en) 2014-06-10 2020-09-15 Ube Industries, Ltd. Crystal of N-substituted sulfonamide compound
CN106458904B (zh) 2014-06-10 2021-12-03 宇部兴产株式会社 N-取代磺酰胺化合物及其制造方法
CA2969856A1 (en) 2014-12-05 2016-06-09 Subramaniam Ananthan Novel quinazolines as biogenic amine transport modulators
EP3226867A4 (en) * 2014-12-05 2018-05-09 Subramaniam Ananthan Heterocyclic compounds as biogenic amine transport modulators
EP3307715A1 (en) * 2015-06-10 2018-04-18 Bayer Pharma Aktiengesellschaft Aromatic sulfonamide derivatives
CU24516B1 (es) 2016-05-03 2021-05-12 Bayer Pharma AG Derivados aromáticos de sulfonamida útiles como medicamentos contra enfermedades asociadas con dolor
CN106432067B (zh) * 2016-09-18 2019-04-19 北京天弘天达医药科技有限公司 一种3-吡啶磺酰氯的绿色化学合成方法
JP2021501178A (ja) * 2017-10-29 2021-01-14 バイエル アクチェンゲゼルシャフトBayer Aktiengesellschaft 虚血性脳卒中の治療のための芳香族スルホンアミド誘導体
CA3097442A1 (en) * 2018-04-20 2019-10-24 Bayer Aktiengesellschaft Heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides
WO2020234103A1 (en) 2019-05-21 2020-11-26 Bayer Aktiengesellschaft Identification and use of kras inhibitors
US20230357239A1 (en) 2020-09-18 2023-11-09 Bayer Aktiengesellschaft Pyrido[2,3-d]pyrimidin-4-amines as sos1 inhibitors
EP4074317A1 (en) 2021-04-14 2022-10-19 Bayer AG Phosphorus derivatives as novel sos1 inhibitors
US20250289806A1 (en) * 2022-04-28 2025-09-18 University Of Miami Compounds for proliferative disorders
WO2024056782A1 (en) 2022-09-16 2024-03-21 Bayer Aktiengesellschaft Sulfone-substituted pyrido[3,4-d]pyrimidine derivatives for the treatment of cancer
CN120112538A (zh) 2022-10-13 2025-06-06 拜耳公司 Sos1抑制剂
WO2025202022A1 (en) 2024-03-27 2025-10-02 Bayer Aktiengesellschaft Anticancer macrocyclic quinazoline-based inhibitors of the ineraction between ras and sos1

Family Cites Families (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3843791A (en) 1973-01-11 1974-10-22 Pfizer Method of killing insects with quinazolinones and quinazoline-thiones
ATE156120T1 (de) 1991-02-07 1997-08-15 Roussel Uclaf Bizyklische stickstoffverbindungen, ihre herstellung, erhaltene zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammensetzungen
US5710158A (en) 1991-05-10 1998-01-20 Rhone-Poulenc Rorer Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
US6645969B1 (en) 1991-05-10 2003-11-11 Aventis Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
AU661533B2 (en) 1992-01-20 1995-07-27 Astrazeneca Ab Quinazoline derivatives
JP2657760B2 (ja) 1992-07-15 1997-09-24 小野薬品工業株式会社 4−アミノキナゾリン誘導体およびそれを含有する医薬品
GB9323290D0 (en) 1992-12-10 1994-01-05 Zeneca Ltd Quinazoline derivatives
KR100297623B1 (ko) 1993-06-17 2001-11-14 오츠까 요시미쯔 포스폰산디에스테르유도체
GB9314893D0 (en) 1993-07-19 1993-09-01 Zeneca Ltd Quinazoline derivatives
GB9314884D0 (en) 1993-07-19 1993-09-01 Zeneca Ltd Tricyclic derivatives
US5654307A (en) 1994-01-25 1997-08-05 Warner-Lambert Company Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
IL112249A (en) 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
IL112248A0 (en) 1994-01-25 1995-03-30 Warner Lambert Co Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them
JPH083144A (ja) 1994-06-21 1996-01-09 Chugai Pharmaceut Co Ltd キナゾリン及びキノリン誘導体
TW414798B (en) 1994-09-07 2000-12-11 Thomae Gmbh Dr K Pyrimido (5,4-d) pyrimidines, medicaments comprising these compounds, their use and processes for their preparation
GB9510757D0 (en) 1994-09-19 1995-07-19 Wellcome Found Therapeuticaly active compounds
GB9424233D0 (en) 1994-11-30 1995-01-18 Zeneca Ltd Quinazoline derivatives
GB9514265D0 (en) 1995-07-13 1995-09-13 Wellcome Found Hetrocyclic compounds
AU7692996A (en) * 1995-12-01 1997-06-27 Ciba-Geigy Ag Receptor antagonists
GB9526546D0 (en) 1995-12-23 1996-02-28 Pfizer Ltd Compounds useful in therapy
US6391874B1 (en) 1996-07-13 2002-05-21 Smithkline Beecham Corporation Fused heterocyclic compounds as protein tyrosine kinase inhibitors
AU7890598A (en) 1996-12-27 1998-07-31 Yoshitomi Pharmaceutical Industries, Ltd. Fused pyrimidine compounds and medicinal use thereof
EP1014953B1 (en) 1997-03-05 2012-04-25 Sugen, Inc. Formulations for hydrophobic pharmaceutical agents
US6184226B1 (en) 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
EE200200119A (et) 1999-09-21 2003-04-15 Astrazeneca Ab Kinasoliini derivaadid ja nende kasutamine ravimitena
AU7738000A (en) * 1999-09-30 2001-04-30 Neurogen Corporation Certain alkylene diamine-substituted heterocycles
AU2001245401A1 (en) 2000-03-01 2001-09-12 Sumitomo Pharmaceuticals Company, Limited Hydrazones and analogs as cholesterol lowering agents
AU5261001A (en) 2000-04-27 2001-11-12 Imperial Cancer Research Technology Ltd Condensed heteroaryl derivatives
PL359920A1 (en) 2000-09-20 2004-09-06 Merck Patent Gmbh 4-amino-quinazolines
US20040044204A1 (en) 2000-09-20 2004-03-04 Werner Mederski 4-amino-quinazolines
WO2002062767A1 (en) 2001-02-07 2002-08-15 Sumitomo Pharmaceuticals Company, Limited Novel quinazoline derivatives
WO2002092579A1 (en) 2001-05-14 2002-11-21 Astrazeneca Ab 4-anilinoquinazoline derivatives
US7829566B2 (en) 2001-09-17 2010-11-09 Werner Mederski 4-amino-quinazolines
US7645878B2 (en) 2002-03-22 2010-01-12 Bayer Healthcare Llc Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
WO2004017950A2 (en) 2002-08-22 2004-03-04 Piramed Limited Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents
AU2003255482A1 (en) 2002-10-02 2004-04-23 Merck Patent Gmbh Use of 4 amino-quinazolines as anti cancer agents
WO2004030671A2 (en) 2002-10-02 2004-04-15 Merck Patent Gmbh Use of 4-amino-quinazolines as anti cancer agents
AU2003292435A1 (en) 2002-12-23 2004-07-14 Astrazeneca Ab 4- (pyridin-4-ylamino) -quinazoline derivatives as anti-tumor agents
WO2004056801A1 (en) 2002-12-23 2004-07-08 Astrazeneca Ab Quinazoline derivatives
WO2004069145A2 (en) 2003-02-07 2004-08-19 Dr. Reddy's Laboratories Ltd. Anticancer compounds, process for their preparation and pharmaceutical compositions containing them
CL2004000409A1 (es) * 2003-03-03 2005-01-07 Vertex Pharma Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
US7713983B2 (en) 2003-03-03 2010-05-11 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
ZA200507979B (en) * 2003-03-03 2007-03-28 Vertex Pharma Inc Quinazolines useful as modulators of ion channels
CN100475793C (zh) 2003-03-31 2009-04-08 大正制药株式会社 喹唑啉衍生物及其制备药物的用途
CN1823071B (zh) 2003-06-11 2012-12-19 润生有限公司 用作钾通道抑制剂的噻吩并嘧啶衍生物
US7410975B2 (en) 2003-06-20 2008-08-12 Coley Pharmaceutical Group, Inc. Small molecule toll-like receptor (TLR) antagonists
CA2531327A1 (en) 2003-07-03 2005-01-13 Myriad Genetics, Inc. Compounds and therapeutical use thereof
EP1667685B1 (en) * 2003-09-23 2012-03-14 Merck Sharp & Dohme Corp. Quinazoline potassium channel inhibitors
CA2543710A1 (en) 2003-11-03 2005-05-12 Warner-Lambert Company Llc Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
TW200538120A (en) 2004-02-20 2005-12-01 Kirin Brewery Compound having TGF-beta inhibitory activity and pharmaceutical composition containing same
WO2005087742A1 (en) 2004-03-08 2005-09-22 Exelixis, Inc. Metabolic kinase modulators and methods of use as pesticides
US20070225308A1 (en) 2004-03-15 2007-09-27 Kyowa Hakko Kogyo Co.,Ltd. 2-Amino Quinazoline Derivative
CA2568304A1 (en) 2004-06-10 2005-12-22 Xention Discovery Limited Furanopyrimidine compounds effective as potassium channel inhibitors
WO2006004722A2 (en) 2004-06-30 2006-01-12 Biomol Research Laboratories, Inc. Compositions and methods for selectively activating human sirtuins
WO2006014420A1 (en) 2004-07-06 2006-02-09 Angion Biomedica Corporation Quinazoline modulators of hepatocyte growth factor / c-met activity for the treatment of cancer
ATE476434T1 (de) 2004-12-09 2010-08-15 Xention Ltd Thienopyridinderivate als kaliumkanalinhibitoren
EP1844023A1 (en) 2004-12-31 2007-10-17 Sk Chemicals Co., Ltd. Quinazoline derivatives for the treatment and prevention of diabetes and obesity
CA2598448A1 (en) 2005-02-18 2006-08-24 Novartis Vaccines And Diagnostics, Inc. Antiangiogenic agents with aldesleukin
NZ556248A (en) 2005-03-14 2010-06-25 Neurosearch As Pyrazolyl-quinazoline potassium channel modulating agents and their medical use
PT1863818E (pt) 2005-03-23 2010-04-09 Hoffmann La Roche Derivados de acetilenil-pirazolo-pirimidina como antagonistas de mglur2
CN101189234B (zh) 2005-03-25 2011-08-17 泰博特克药品有限公司 Hcv的杂二环抑制剂
BRPI0609650A2 (pt) 2005-03-25 2010-04-20 Tibotec Pharm Ltd inibidores heterobicìlicos de hvc
EP1878727A4 (en) 2005-04-28 2013-11-13 Kyowa Hakko Kirin Co Ltd 2-AMINOQUINAZOLINE DERIVATIVES
WO2007002781A2 (en) 2005-06-28 2007-01-04 Bausch & Lomb Incorporated Preparations comprising arylazine substituted with a carbonylic moiety to increase the activity of gelatinase a in ocular cells
GB0525164D0 (en) 2005-12-09 2006-01-18 Xention Discovery Ltd Compounds
WO2007071632A2 (en) 2005-12-20 2007-06-28 Neurosearch A/S 2-pyridin-2-yl-quinazoline derivatives as potassium channel modulating agents for the treatment of respiratory diseases
JP2009520700A (ja) 2005-12-21 2009-05-28 ペインセプター ファーマ コーポレーション 依存性イオンチャネルを調節するための組成物および方法
DE102006012251A1 (de) 2006-03-15 2007-11-08 Grünenthal GmbH Substituierte 4-Amino-chinazolin-Derivate und ihre Verwendung zur Herstellung von Arzneimitteln
AU2007271187A1 (en) 2006-07-03 2008-01-10 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg Fused bicyclic compounds interacting with the histamine H4 receptor
EP2589597B1 (en) 2006-08-22 2019-03-06 Technion Research & Development Foundation Heterocyclic derivatives binding to the peripheral-type benzodiazepine receptor (PBR)
US20100173332A1 (en) 2006-09-07 2010-07-08 Auckland Uniservices Limited Method for the Fluorescent Detection of Nitroreductase Activity Using Nitro-Substituted Aromatic Compounds
WO2008045529A1 (en) 2006-10-12 2008-04-17 Serenex, Inc. Purine and pyrimidine derivatives for treatment of cancer and inflammatory diseases
US8039505B2 (en) 2007-04-11 2011-10-18 University Of Utah Research Foundation Compounds for modulating T-cells
PE20090717A1 (es) * 2007-05-18 2009-07-18 Smithkline Beecham Corp Derivados de quinolina como inhibidores de la pi3 quinasa
EP2154965A4 (en) 2007-05-29 2011-08-17 Glaxosmithkline Llc NAPHTHYRIDINE DERIVATIVES AS P13 KINASE INHIBITORS
US9603848B2 (en) 2007-06-08 2017-03-28 Senomyx, Inc. Modulation of chemosensory receptors and ligands associated therewith
WO2009006141A2 (en) 2007-07-05 2009-01-08 Bausch & Lomb Incorporated Authority to read as follows: compositions and methods for treating or controlling infections of the eye a sequelae thereof
US7829574B2 (en) 2008-05-09 2010-11-09 Hutchison Medipharma Enterprises Limited Substituted quinazoline compounds and their use in treating angiogenesis-related diseases
CN101575333B (zh) 2008-05-09 2011-06-22 和记黄埔医药(上海)有限公司 一种喹唑啉衍生物及其医药用途
US20110098305A1 (en) 2008-05-21 2011-04-28 Jonathan Bayldon Baell Arylsulfonamide compounds, compositions and methods of use
EP2473487B1 (en) 2009-09-03 2016-10-26 Bristol-Myers Squibb Company Quinazolines as potassium ion channel inhibitors
AU2010289321A1 (en) 2009-09-04 2012-04-05 The Regents Of The University Of Michigan Compositions and methods for treatment of leukemia
AR079814A1 (es) 2009-12-31 2012-02-22 Otsuka Pharma Co Ltd Compuestos heterociclicos, composiciones farmaceuticas que los contienen y sus usos

Similar Documents

Publication Publication Date Title
JP5950978B2 (ja) カリウムイオンチャネルインヒビターとしてのキナゾリン
JP5539734B2 (ja) チオピリミジンベースの化合物およびその使用
KR102007056B1 (ko) 과증식성 질환 치료시 Bub1 키나제 저해제로 사용하기 위한 치환된 벤질인다졸
ES2770026T3 (es) Derivados de imidazotiazol e imidazopirazina como inhibidores del receptor activado por proteasa 4 (PAR4) para tratar la agregación plaquetaria
AU2007328008B2 (en) Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
ES2873949T3 (es) Moduladores del receptor de glucocorticoides de azadecalina condensada con heteroaril-cetona
JP5756518B2 (ja) 複素環アルキニルベンゼン化合物と、その医療用組成物および使用
HRP20180413T1 (hr) Inhibitori kinaza koji reguliraju signalne puteve u apoptozi
RU2018138047A (ru) Гетероциклические вещества - агонисты gpr119
JP2019504009A5 (cg-RX-API-DMAC7.html)
JP2023506642A5 (cg-RX-API-DMAC7.html)
TWI455715B (zh) 4-(4-氰基-2-硫基芳基)二氫嘧啶酮類及其用途
CA2624602A1 (en) Process for preparing 6-substituted-7-azaindoles
TW200536851A (en) Compounds and methods of use
EP2063897A2 (en) Kinase inhibitors useful for the treatment of proliferative diseases
BRPI0720270A2 (pt) Compostos basedos em 4-fenil-6-(2,2,2-triflúor-1-fenil etoxi) pirimidina e processos de usos dos mesmos
JP2014525444A5 (cg-RX-API-DMAC7.html)
WO2012087938A1 (en) Quinazolinone derivatives as antiviral agents
JP2011503230A5 (cg-RX-API-DMAC7.html)
JP2006507247A5 (cg-RX-API-DMAC7.html)
RU2015128025A (ru) Ингибиторы сомт
JP2012522748A5 (cg-RX-API-DMAC7.html)
JP2018508553A5 (cg-RX-API-DMAC7.html)
RU2005103618A (ru) Ингибирующие циклооксигеназу-2 (цог-2) производные пиридина
JP2006528147A5 (cg-RX-API-DMAC7.html)